LifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…
Following the success of our neuroscience-focused ion channel drug discovery collaboration, we look forward to cont… https://t.co/29sXTbab5x
LifeArc and Cleveland Clinic collaborate to advance early stage research towards patients
LifeArc to fund two post-doctoral fellowships focused on drug discovery In November 2020, LifeArc initiated a new…
KQ Labs Accelerator welcomes 10 innovative start-ups
London, UK - KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick…
UK DRI appoints LifeArc to support translation of discoveries into treatments
LifeArc has been appointed by the UK Dementia Research Institute (UK DRI) to provide expertise to accelerate…
LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics
Funding to help drive the development of new cancer therapies
Biocartis expands collaboration with LifeArc
Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an…
LifeArc appoints Dr Ian Campbell as Chief Business Officer
Former Innovate UK Executive Chair joins charity to drive new collaborations and partnerships to benefit patient health.
LifeArc appoints Clare Terlouw to lead its life sciences investment strategy
Clare will be responsible for LifeArc’s investments across the life science sector
KQ Labs opens accelerator programme and announces LifeArc as a strategic partner
KQ Labs is now accepting applications for its third cohort of companies. Early stage data-driven health companies…